Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,744 | -10,507 | 3,667 | 21,243 | -66,894 |
| Depreciation Amortization | 584 | 329 | 128 | 33 | -390 |
| Accounts receivable | -5,862 | -4,520 | -1,616 | 451 | -6,034 |
| Accounts payable and accrued liabilities | -331 | -1,869 | -738 | -1,945 | -2,239 |
| Other Working Capital | -30,322 | -32,100 | -24,707 | -26,393 | 16,659 |
| Other Operating Activity | 13,490 | 12,054 | 6,135 | 3,518 | 17,388 |
| Operating Cash Flow | $-52,185 | $-36,613 | $-17,131 | $-3,093 | $-41,510 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 48,728 | 39,513 | 19,790 | 25,068 | -22,201 |
| PPE Investments | -1,262 | -758 | -563 | -607 | -1,455 |
| Investing Cash Flow | $47,466 | $38,755 | $19,227 | $24,461 | $-23,656 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 9,975 | N/A | N/A | N/A | 9,789 |
| Common Stock Issued | 2,596 | 1,929 | 1,877 | 1,336 | 1,576 |
| Other Financing Activity | 0 | 9,975 | 9,975 | 0 | 0 |
| Financing Cash Flow | $12,571 | $11,904 | $11,852 | $1,336 | $11,365 |
| Beginning Cash Position | 22,521 | 22,521 | 22,521 | 22,521 | 76,322 |
| End Cash Position | 30,373 | 36,567 | 36,469 | 45,225 | 22,521 |
| Net Cash Flow | $7,852 | $14,046 | $13,948 | $22,704 | $-53,801 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,185 | -36,613 | -17,131 | -3,093 | -41,510 |
| Capital Expenditure | -1,262 | -758 | -563 | -607 | -1,455 |
| Free Cash Flow | -53,447 | -37,371 | -17,694 | -3,700 | -42,965 |